{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T14:49:09Z","timestamp":1746197349793,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Natural Science Foundation of Fujian","award":["2022J011004"],"award-info":[{"award-number":["2022J011004"]}]},{"DOI":"10.13039\/100016086","name":"Key Laboratory in Science and Technology Development Project of Suzhou","doi-asserted-by":"publisher","award":["KJXW2020004"],"award-info":[{"award-number":["KJXW2020004"]}],"id":[{"id":"10.13039\/100016086","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Medical Innovation Project of Fujian","award":["2022CXB001"],"award-info":[{"award-number":["2022CXB001"]}]},{"name":"Natural Science Foundation of Fujian","award":["2023J011178"],"award-info":[{"award-number":["2023J011178"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s10067-023-06750-1","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T07:02:38Z","timestamp":1694415758000},"page":"3113-3121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Increased ILT2+ natural killer T cells correlate with disease activity in systemic lupus erythematosus"],"prefix":"10.1007","volume":"42","author":[{"given":"Ning","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianming","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiuyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5240-8492","authenticated-orcid":false,"given":"Qing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,11]]},"reference":[{"key":"6750_CR1","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365:2110\u20132121","journal-title":"N Engl J Med"},{"issue":"10188","key":"6750_CR2","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/S0140-6736(19)30546-X","volume":"393","author":"T D\u00f6rner","year":"2019","unstructured":"D\u00f6rner T, Furie R (2019) Novel paradigms in systemic lupus erythematosus. Lancet 393(10188):2344\u20132358","journal-title":"Lancet"},{"key":"6750_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.coi.2016.09.001","volume":"43","author":"A Suarez-fueyo","year":"2016","unstructured":"Suarez-fueyo A, Bradley SJ, Tsokos GC (2016) T cells in systemic lupus erythematosus. Curr Opin Immunol 43:32\u201338","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"6750_CR4","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1002\/art.30313","volume":"63","author":"B Hervier","year":"2011","unstructured":"Hervier B, Beziat V, Haroche J, Mathian A, Lebon P, Ghillani-Dalbin P et al (2011) Phenotype and function of natural killer cells in systemic lupus erythematosus. Arthritis Rheum 63(6):1698\u20131706","journal-title":"Arthritis Rheum"},{"issue":"4","key":"6750_CR5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1189\/jlb.4RU0315-081RR","volume":"98","author":"R Spada","year":"2015","unstructured":"Spada R, Rojas JM, Barber DF (2015) Recent findings on the role of natural killer cells in the pathogenesis of systemic lupus erythematosus. J Leukoc Biol 98(4):479\u2013487","journal-title":"J Leukoc Biol"},{"key":"6750_CR6","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1002\/art.24556","volume":"60","author":"YW Park","year":"2009","unstructured":"Park YW, Kee SJ, Cho YN, Lee EH, Lee HY, Kim EM et al (2009) Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. Arthritis rheum 60:1753\u20131763","journal-title":"Arthritis rheum"},{"key":"6750_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/ni.1841","volume":"11","author":"DI Godfrey","year":"2010","unstructured":"Godfrey DI, Stankovic S, Baxter AG (2010) Raising the NKT cell family. Nat immunol 11:197\u2013206","journal-title":"Nat immunol"},{"key":"6750_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/art.22326","volume":"56","author":"MR Green","year":"2007","unstructured":"Green MR, Kennell AS, Larche MJ, Seifert MH, Isenberg DA, Salaman MR (2007) Natural killer T cells in families of patients with systemic lupus erythematosus: their possible role in regulation of IGG production. Arthritis rheum 56:303\u2013310","journal-title":"Arthritis rheum"},{"issue":"6","key":"6750_CR9","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/1756-185X.12289","volume":"19","author":"Y Zhuang","year":"2016","unstructured":"Zhuang Y, Ning M, Ling Z, Zhen-Yu J, Yan-Fang J (2016) Differential expression of natural killer activating and inhibitory receptors in patients with newly diagnosed systemic lupus erythematosus. Int J Rheum Dis 19(6):613\u2013621","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"6750_CR10","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1177\/09612033231160979","volume":"32","author":"N Lucia","year":"2023","unstructured":"Lucia N, Cristiana B, Cristina C, Serena R, Fulvia C, Marta V et al (2023) KLRG1 is reduced on NK cells in SLE patients, inversely correlates with disease activity and is modulated by hydroxychloroquine in vitro. Lupus 32(4):549\u2013559","journal-title":"Lupus"},{"issue":"3","key":"6750_CR11","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/cei.13073","volume":"191","author":"DJ de Cruz-Gonz\u00e1lez","year":"2018","unstructured":"de Cruz-Gonz\u00e1lez DJ, G\u00f3mez-Martin D, Layseca-Espinosa E, Baranda L, Abud-Mendoza C, Alcocer-Varela J et al (2018) Analysis of the regulatory function of natural killer cells from patients with systemic lupus erythematosus. Clin Exp Immunol 191(3):288\u2013300","journal-title":"Clin Exp Immunol"},{"key":"6750_CR12","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.4049\/jimmunol.168.7.3351","volume":"168","author":"T Bell\u00f3n","year":"2002","unstructured":"Bell\u00f3n T, Kitzig F, Say\u00f3s J, L\u00f3pez-Botet M (2002) Mutational analysis of immunoreceptor tyrosine-based inhibition motifs of the Ig-like transcript 2 (CD85j) leukocyte receptor. J Immunol 168:3351\u20133359","journal-title":"J Immunol"},{"key":"6750_CR13","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1182\/blood-2009-09-243493","volume":"115","author":"DL Lamar","year":"2010","unstructured":"Lamar DL, Weyand CM, Goronzy JJ (2010) Promoter choice and translational repression determine cell type-specific cell surface density of the inhibitory receptor CD85j expressed on different hematopoietic lineages. Blood 115:3278\u20133286","journal-title":"Blood"},{"issue":"9","key":"6750_CR14","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725","journal-title":"Arthritis Rheum"},{"key":"6750_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00005-019-00537-6","volume":"67","author":"AM Zahran","year":"2019","unstructured":"Zahran AM, Abdel-Rahim MH, Elsayh KI, Hassanien MM, Mahran SA, Hetta HF (2019) Natural killer and natural killer t cells in juvenile systemic lupus erythematosus: relation to disease activity and progression. Arch Immuno Ther Ex 67:161\u2013169","journal-title":"Arch Immuno Ther Ex"},{"key":"6750_CR16","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s10067-020-05306-x","volume":"40","author":"M Liu","year":"2021","unstructured":"Liu M, Liu J, Zhang X, Xiao Y, Jiang G, Huang X (2021) Activation status of CD56(dim) natural killer cells is associated with disease activity of patients with systemic lupus erythematosus. Clin Rheumatol 40:1103\u20131112","journal-title":"Clin Rheumatol"},{"key":"6750_CR17","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3109\/08880018.2011.613092","volume":"28","author":"SJ Lin","year":"2011","unstructured":"Lin SJ, Kuo ML (2011) Cytotoxic function of umbilical cord blood natural killer cells: relevance to adoptive immunotherapy. Pediatr Hemat Oncol 28:640\u2013646","journal-title":"Pediatr Hemat Oncol"},{"key":"6750_CR18","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nri1309","volume":"4","author":"DI Godfrey","year":"2004","unstructured":"Godfrey DI, Macdonald HR, Kronenberg M, Smyth MJ, Van Kaer L (2004) NKT cells: what\u2019s in a name? Nat Rev Immunol 4:231\u2013237","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"6750_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13075-022-02731-y","volume":"24","author":"Z Lu","year":"2022","unstructured":"Lu Z, Tian Y, Bai Z, Liu J, Zhang Y, Qi J, Jin M, Zhu J, Li X (2022) Increased oxidative stress contributes to impaired peripheral CD56dimCD57+ NK cells from patients with systemic lupus erythematosus. Arthritis Res Ther 24(1):48","journal-title":"Arthritis Res Ther"},{"key":"6750_CR20","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s10067-020-05306-x","volume":"40","author":"L Manman","year":"2021","unstructured":"Manman L, Junli L, Xiaoyan Z, Yichuan X, Gengru J, Xinfang H (2021) Activation status of CD56dim natural killer cells is associated with disease activity of patients with systemic lupus erythematosus. Clin Rheumatol 40:1103\u20131112","journal-title":"Clin Rheumatol"},{"key":"6750_CR21","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.immuni.2012.02.008","volume":"36","author":"A Bosma","year":"2012","unstructured":"Bosma A, Abdel-Gadir A, Isenberg DA, Jury EC, Mauri C (2012) Lipid-antigen presentation by CD1d(+) B cells is essential for the maintenance of invariant natural killer T cells. Immunity 36:477\u2013490","journal-title":"Immunity"},{"issue":"1","key":"6750_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10238-021-00726-8","volume":"22","author":"L Qing","year":"2022","unstructured":"Qing L, Yunyuan K, Biqi F, Xue L, Qingshui H, Zikun H et al (2022) Increased TIM-3+PD-1+ NK cells are associated with the disease activity and severity of systemic lupus erythematosus. Clin Exp Med 22(1):47\u201356","journal-title":"Clin Exp Med"},{"key":"6750_CR23","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/cei.13263","volume":"196","author":"K Hudspeth","year":"2019","unstructured":"Hudspeth K, Wang S, Wang J, Rahman S, Smith MA, Casey KA et al (2019) Natural killer cell expression of Ki67 is associated with elevated serum IL-15, disease activity and nephritis in systemic lupus erythematosus. Clin Exp Immunol 196:226\u2013236","journal-title":"Clin Exp Immunol"},{"key":"6750_CR24","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1080\/08820130902770003","volume":"38","author":"PT Wong","year":"2009","unstructured":"Wong PT, Wong CK, Tam LS, Li EK, Chen DP, Lam CW (2009) Decreased expression of T lymphocyte co-stimulatory molecule CD26 on invariant natural killer T cells in systemic lupus erythematosus. Immunol Invest 38:350\u2013364","journal-title":"Immunol Invest"},{"key":"6750_CR25","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jaut.2007.05.003","volume":"29","author":"A Monsiv\u00e1is-urenda","year":"2007","unstructured":"Monsiv\u00e1is-urenda A, Ni\u00f1o-moreno P, Abud-mendoza C, Baranda L, Layseca-espinosa E, L\u00f3pez-botet M (2007) Analysis of expression and function of the inhibitory receptor ILT2 (CD85j\/LILRB1\/LIR-1) in peripheral blood mononuclear cells from patients with systemic lupus erythematosus (SLE). J Autoimmun 29:97\u2013105","journal-title":"J Autoimmun"},{"key":"6750_CR26","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/j.1365-3083.2006.01849.x","volume":"64","author":"N Figueroa-vega","year":"2006","unstructured":"Figueroa-vega N, Galindo-rodr\u00edguez G, Baja\u00f1a S, Portales-P\u00e9rez D, Abud-mendoza C, S\u00e1nchez-torres C et al (2006) Phenotypic analysis of IL-10-treated, monocyte-derived dendritic cells in patients with systemic lupus erythematosus. Scand J Immunol 64:668\u2013676","journal-title":"Scand J Immunol"},{"key":"6750_CR27","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s10238-012-0185-6","volume":"13","author":"J Chen","year":"2013","unstructured":"Chen J, Shen B, Jiang Y, Jun L, Zhu M, Chen B et al (2013) Analysis of immunoglobulin-like transcripts (ILTs) in lymphocytes with sHLA-G and IL10 from SLE patients. Clin Exp Med 13:135\u2013142","journal-title":"Clin Exp Med"},{"key":"6750_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1084\/jem.20082013","volume":"206","author":"ND Huntington","year":"2009","unstructured":"Huntington ND, Legrand N, Alves NL, Jaron B, Weijer K, Plet A et al (2009) IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med 206:25\u201334","journal-title":"J Exp Med"},{"key":"6750_CR29","doi-asserted-by":"publisher","first-page":"e0186223","DOI":"10.1371\/journal.pone.0186223","volume":"12","author":"SJ Lin","year":"2017","unstructured":"Lin SJ, Kuo ML, Hsiao HS, Lee PT, Chen JY, Huang JL (2017) Activating and inhibitory receptors on natural killer cells in patients with systemic lupus erythematosis-regulation with interleukin-15. PLoS One 12:e0186223","journal-title":"PLoS One"},{"key":"6750_CR30","doi-asserted-by":"publisher","first-page":"4236562","DOI":"10.1155\/2019\/4236562","volume":"2019","author":"SJ Lin","year":"2019","unstructured":"Lin SJ, Kuo ML, Hsiao HS, Lee PT, Lee WI, Chen JY et al (2019) Cytotoxic function and cytokine production of natural killer cells and natural killer t-like cells in systemic lupus erythematosis regulation with interleukin-15. Mediators Inflamm 2019:4236562","journal-title":"Mediators Inflamm"},{"key":"6750_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12936-016-1131-y","volume":"15","author":"TC D'almeida","year":"2016","unstructured":"D\u2019almeida TC, Sadissou I, Cottrell G, Tahar R, Moreau P, Favier B et al (2016) Evolution of the levels of human leukocyte antigen G (HLA-G) in Beninese infant during the first year of life in a malaria endemic area: using latent class analysis. Malaria J 15:78","journal-title":"Malaria J"},{"issue":"1","key":"6750_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.2174\/1573397118666220617100226","volume":"19","author":"Z Rezaieyazdi","year":"2023","unstructured":"Rezaieyazdi Z, Rezaeian A, Khodashahi M (2023) Serum level of soluble human leukocyte antigen G in patients with systemic lupus erythematosus and rheumatoid arthritis. Curr Rheumatol Rev 19(1):64\u201371","journal-title":"Curr Rheumatol Rev"},{"key":"6750_CR33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00393-020-00783-6","volume":"80","author":"SC Bae","year":"2021","unstructured":"Bae SC, Lee YH (2021) Association of HLA-G polymorphisms with systemic lupus erythematosus and correlation between soluble HLA-G levels and the disease: a meta-analysis. Z rheumatol 80:96\u2013102","journal-title":"Z rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06750-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06750-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06750-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T10:14:06Z","timestamp":1697710446000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06750-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["6750"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06750-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2023,9,11]]},"assertion":[{"value":"29 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of Fujian Provincial Hospital. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}